G
Giuseppe Pinto
Publications - 9
Citations - 289
Giuseppe Pinto is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 1 publications receiving 143 citations.
Papers
More filters
Journal ArticleDOI
Characterization of Myocardial Injury in Patients With COVID-19.
Gennaro Giustino,Lori B. Croft,Giulio G. Stefanini,Renato Bragato,Jeffrey J. Silbiger,Marco Vicenzi,Tatyana Danilov,Nina Kukar,Nada Shaban,Annapoorna Kini,Anton Camaj,Solomon Bienstock,Eman Rashed,Karishma Rahman,Connor P. Oates,Samantha Buckley,Lindsay Elbaum,Derya Arkonac,Ryan Fiter,Ranbir Singh,Emily Li,Victor Razuk,Sam E. Robinson,Michael L. Miller,Benjamin Bier,Valeria Donghi,Marco Pisaniello,Riccardo Mantovani,Giuseppe Pinto,Irene Rota,Sara Baggio,Mauro Chiarito,Fabio Fazzari,Ignazio Cusmano,Mirko Curzi,Richard Ro,Waqas Malick,Mazullah Kamran,Roopa Kohli-Seth,Adel Bassily-Marcus,Eric Neibart,Gregory Serrao,Gila Perk,Donna M. Mancini,Vivek Y. Reddy,Sean Pinney,George Dangas,Francesco Blasi,Samin K. Sharma,Roxana Mehran,Gianluigi Condorelli,Gregg W. Stone,Valentin Fuster,Stamatios Lerakis,Martin E. Goldman +54 more
TL;DR: An international, multicenter cohort study including 7 hospitals in New York City and Milan of hospitalized patients with laboratory-confirmed COVID-19 who had undergone transthoracic echocardiographic (TTE) and electrocardiographic evaluation during their index hospitalization found cardiac structural abnormalities were present in nearly two-thirds of patients with myocardial injury.
Journal ArticleDOI
Transcatheter aortic valve replacement in aortic stenosis and cardiac amyloidosis: a systematic review and meta‐analysis
Francesco Cannata,Mauro Chiarito,Giuseppe Pinto,A Villaschi,Jorge Sanz-Sánchez,Fabio Fazzari,Damiano Regazzoli,Antonio Mangieri,Renato Bragato,Antonio Colombo,Bernhard Reimers,Gianluigi Condorelli,Giulio G. Stefanini +12 more
TL;DR: TAVR is an effective and safe procedure in CA-AS patients, with a substantial survival benefit as compared with medical therapy, and a safety profile comparable with patients with AS alone except for a trend towards higher risk of permanent pacemaker implantation.
Journal ArticleDOI
Aortic valve stenosis: drivers of disease progression and drug targets for therapeutic opportunities
Giuseppe Pinto,Gabriele Fragasso +1 more
TL;DR: This paper offers a brief overview of molecular mechanisms leading to calcification of aortic valve, then focused on potential markers of disease progression, as observed in many observational studies, and provides a comprehensive review of drugs already tested in in vitro and human studies in order to slow aortIC valve stenosis process.
Journal ArticleDOI
144 long-term prognostic impact of subclinical myocardial dysfunction in patients recovered from covid-19
Francesco Cannata,Giuseppe Pinto,Mauro Chiarito,Matteo Maurina,F. Condello,S. Bombace,A Villaschi,L. Novelli,Kamil Stankowski,Gaetano Liccardo,Gaia Gasparini,Dario Donia,Anastasia Celata,Ilaria My,Marinos Kallikourdis,Stefano Figliozzi,Riccardo Mantovani,Fabio Fazzari,Renato Bragato,Gianluigi Condorelli,Giulio G. Stefanini +20 more
TL;DR: In this paper , the long-term prognostic role of subclinical myocardial dysfunction and long-COVID condition in patients recovered from COVID-19 pneumonia was defined.
Journal ArticleDOI
185 beta-blockers or calcium channel blockers in hypertrophic cardiomyopathy
Giuseppe Pinto,Mauro Chiarito,A. M. Bacher,Tania Puscas,Gianluigi Condorelli,Patricia Reant,Erwan Donal,Albert Hagège +7 more
TL;DR: This paper evaluated the prognostic impact of betablockers (BB) and non-dihydropyridine calcium channel blockers (ND-CCB) in hypertrophic cardiomyopathy (HCM) patients.